USCB Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher DLTR Q1 2026 Earnings Small EPS Miss Amid Cautious Consumer Spending NAII Q2 2024 Earnings Reported Loss Deepens as Stock Declines Fulcrum Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Analyst Expectations UGRO Q3 2025 Earnings Significant EPS Miss Amidst Industry Challenges NPWR Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Company Continues Technology Development